Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA accepts supplemental BLA and grants priority review for pediatric use of Coagadex

May 24, 2018

Spero presents positive top-line data for SPR-741 and SPR-206

May 24, 2018

U.K. Government and the Bill & Melinda Gates Foundation join CARB-X partnership

May 24, 2018

FDA accepts NDA for Zynquista as potential treatment for type 1 diabetes

May 24, 2018

FDA grants breakthrough therapy designation for Tafamidis

May 24, 2018

Lava Therapeutics to advance its bispecific gamma-delta T cell engager platform

May 24, 2018

FDA grants breakthrough therapy designation to Lenti-D investigational gene therapy

May 24, 2018

Cosmo Pharmaceuticals receives FDA complete response letter for Methylene Blue MMX

May 24, 2018

Clinigen and Mitsubishi Tanabe Pharma partner for European Managed Access Program for edaravone

May 24, 2018

Rhinovirus vaccine uses capsid proteins to generate neutralizing antibodies

May 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...